Clinical Trial Update: Secondary Prevention of Clostridioides Difficile Using Vancomycin [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes ongoing Phase 2/3 studies evaluating vancomycin for secondary prevention of Clostridioides difficile infection and recurren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence | Phase 2, Phase 3 | Status: RECRUITING